Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

About ecancer

Dr Enrique Soto - The University of Colorado Anschutz Medical Campus, Colorado, USA
About ecancer ( Dr Enrique Soto - The University of Colorado Anschutz Medical Campus, Colorado, USA )
21 Sep 2024

Neoadjuvant ipilimumab added to nivolumab improves outcomes in resectable advanced melanoma

Dr Minke W. Lucas - The Netherlands Cancer Institute, Amsterdam, Netherlands
Neoadjuvant ipilimumab added to nivolumab improves outcomes in resectable advanced melanoma ( Dr Minke W. Lucas - The Netherlands Cancer Institute, Amsterdam, Netherlands )
19 Sep 2024

ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer

Prof Karim Fizazi, Dr Anders Bjartell, Dr Niven Mehra and Prof Eleni Efstathiou
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer ( Prof Karim Fizazi, Dr Anders Bjartell, Dr Niven Mehra and Prof Eleni Efstathiou )
19 Sep 2024

No benefit for adjuvant durvalumab in completely resected NSCLC

Prof Glenwood Goss - University of Ottawa, Ottawa, Canada
No benefit for adjuvant durvalumab in completely resected NSCLC ( Prof Glenwood Goss - University of Ottawa, Ottawa, Canada )
17 Sep 2024

PFS increase but no OS increase for niraparib in advanced ovarian cancer

Dr Antonio González-Martín - Cancer Center Clínica Universidad de Navarra, Madrid, Spain
PFS increase but no OS increase for niraparib in advanced ovarian cancer ( Dr Antonio González-Martín - Cancer Center Clínica Universidad de Navarra, Madrid, Spain )
17 Sep 2024

ESMO 2024: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2024: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )
16 Sep 2024

Watchful waiting vs intravesical BCG in high grade pT1 bladder cancer

Dr Hiroshi Kitamura - University of Toyama, Toyama, Japan
Watchful waiting vs intravesical BCG in high grade pT1 bladder cancer ( Dr Hiroshi Kitamura - University of Toyama, Toyama, Japan )
16 Sep 2024

Durvalumab and oleclumab boost for SBRT plus chemo in ER+/HER2- breast cancer

Dr Alex De Caluwe - Institut Jules Bordet, Brussels, Belgium
Durvalumab and oleclumab boost for SBRT plus chemo in ER+/HER2- breast cancer ( Dr Alex De Caluwe - Institut Jules Bordet, Brussels, Belgium )
16 Sep 2024

Faecal microbiota transplantation increases activity of immunotherapy in mRCC

Dr Chiara Ciccarese - Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
Faecal microbiota transplantation increases activity of immunotherapy in mRCC ( Dr Chiara Ciccarese - Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy )
16 Sep 2024

Zanidatamab investigated for HER2+ advanced or metastatic gastro-oesophageal adenocarcinoma

Dr Elena Elimova - The Princess Margaret Hospital, Toronto, Canada
Zanidatamab investigated for HER2+ advanced or metastatic gastro-oesophageal adenocarcinoma ( Dr Elena Elimova - The Princess Margaret Hospital, Toronto, Canada )
16 Sep 2024

Novel antibody drug conjugate TORL-1-23 shows preliminary antitumour activity in heavily-pretreated ovarian, endometrial, and testicular cancers

Prof Gottfried Konecny - University of California, Los Angeles, USA
Novel antibody drug conjugate TORL-1-23 shows preliminary antitumour activity in heavily-pretreated ovarian, endometrial, and testicular cancers ( Prof Gottfried Konecny - University of California, Los Angeles, USA )
16 Sep 2024

Total neoadjuvant treatment without surgery for locally advanced rectal cancer

Dr Alessio Amatu - Niguarda Cancer Center, Milan, Italy
Total neoadjuvant treatment without surgery for locally advanced rectal cancer ( Dr Alessio Amatu - Niguarda Cancer Center, Milan, Italy )
16 Sep 2024